Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Genome Biologics

Genome Biologics
PRIVATE STATUS
Grant LATEST DEAL TYPE
$61.6K LATEST DEAL AMOUNT
4 INVESTORS
Description

Owner and operator of a Biotherapeutics company intended to facilitate drug screening and therapeutics development. The company's services focus on molecular and functional drug repositioning by combining a computational AI based drug-disease matching platform so as to analyze massive data resources and identify non-obvious, mechanism-of-action based associations between compounds, molecular targets and diseases, enabling medical researchers to reduce the cost of research, identify new treatments and accelerate drug development.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • Lange Strasse 59
  • 60311 Frankfurt
  • Germany

+49 069 00000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Genome Biologics’s full profile, request a free trial.

Genome Biologics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 09-Apr-2018 $61.6K Completed Startup
1. Accelerator/Incubator 23-Mar-2018 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Genome Biologics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Horizon 2020 Government 000 0000 000000 0
Bioqube Ventures Venture Capital Minority 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0
European Commission Government 000 0000 000000 0

Genome Biologics Executive Team (2)

Name Title Board
Seat
Contact
Info
Jonathan Ward Co-Founder & Chief Executive Officer
Jaya Krishnan Ph.D Co-Founder & Chief Technology Officer